Literature DB >> 29279361

Cystic Fibrosis 2017-The Year in Review.

Bruce K Rubin1.   

Abstract

It is always an exciting challenge to write a Year in Review artcicle identifying the best publications in the preceding year; in this case from October 2016 until the AARC meeting in October 2017. This is particularly true for cystic fibrosis (CF), where there has been an explosion of new data, new medications, and new understanding of the pathophysiology of the disease. PubMed lists more than 2,500 papers published during those 12 months, many of them outstanding. I am indebted to many colleagues and friends who are leaders in the CF community, active readers of the pediatric pulmonary listserv, and scientists and clinicians engaged in the care of CF, for offering their suggestions regarding which articles should be included in this review. I believe that you will enjoy reading this curated selection of manuscripts that I have tried to organize by theme.
Copyright © 2018 by Daedalus Enterprises.

Entities:  

Keywords:  CF exacerbations; CF outcomes; CFTR modulators; adherence to therapy; cystic fibrosis; risk factors

Mesh:

Year:  2017        PMID: 29279361     DOI: 10.4187/respcare.06052

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  2 in total

1.  Nitric oxide diffusion through cystic fibrosis-relevant media and lung tissue.

Authors:  Jackson R Hall; Sara E Maloney; Haibao Jin; James B Taylor; Mark H Schoenfisch
Journal:  RSC Adv       Date:  2019-12-04       Impact factor: 4.036

Review 2.  The Use of Artificial Sputum Media to Enhance Investigation and Subsequent Treatment of Cystic Fibrosis Bacterial Infections.

Authors:  Aditi Aiyer; Jim Manos
Journal:  Microorganisms       Date:  2022-06-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.